Journal Article Summary

The article investigates the antifungal effects of two medications, voriconazole and nystatin, on Candida species found in patients undergoing radiotherapy for head and neck cancers. This topic is significant because radiotherapy can lead to complications like oral candidiasis, which is an infection caused by Candida fungi. Understanding the effectiveness of these antifungal treatments is crucial for managing infections in patients who are already vulnerable due to their cancer treatment.

In this study, researchers collected samples from 33 patients before and two weeks after they began radiotherapy. They used laboratory methods to identify the Candida species and to measure how effective voriconazole and nystatin were against these fungi. The findings revealed that all Candida species were sensitive to nystatin both before and after radiotherapy, while some strains showed resistance to voriconazole. Specifically, a percentage of Candida albicans and non-albicans species were resistant to voriconazole, indicating that nystatin may be a more reliable treatment option in this context.

However, the study has limitations, including its in vitro nature, which means the results may not fully reflect how these treatments work in real patients. Additionally, while nystatin showed consistent effectiveness, it may not be as well tolerated by patients experiencing side effects from their cancer treatments. Patients should discuss their treatment options and any concerns about antifungal medications with their healthcare providers to ensure they receive the most appropriate care for their specific situation.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Khozeimeh Faezeh, Nezhad Zahra Golestan, Dehghan Parvin, Tabesh Adel, Kheirkhah Mahnaz, Jamshidi Mina, Chermahini Ahmad Amiri, Sadeghalbanaei Leila, et al.. Evaluation and comparison of antifungal effect of voriconazole with nystatin on candida species derived from neoplastic patients undergoing maxillofacial radiotherapy. Dental Research Journal 2023. PMID: 37674568. PMCID: PMC10478833.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]